CMO - Chief Medical Officer | Drug Discovery Scientist

CMO - Chief Medical Officer | Drug Discovery Scientist

Join generalAI: Shape the Future of AI-Powered Drug Discovery

The Opportunity

We're building the world's first 36-algorithm ASI/AGI platform for drug discovery, and we need a visionary Chief Marketing Officer to tell our story to the world.

You'll lead marketing strategy for a CHF 43-72 TRILLION drug portfolio (representing ~14% of global wealth) across 76 therapeutic areas. This is not a computational role - it's a business development and commercial strategy position for someone with deep pharmaceutical and biotech industry expertise.

Why This Matters

What we've built: 20,000 drug candidates discovered in 100 batches across oncology, immunology, neurology, rare disease, and exotic therapeutic frontiers

Our platform's edge: Multi-modality support (small molecules, biologics, gene therapy, cell therapy, advanced modalities)

Your playground: 20,000+ novel compounds with regulatory-ready potential, clinical protocols in place, synthesis recipes documented

Market scale: Portfolio value CHF 43-72 TRILLION across all indications

Who We're Looking For

Essential Background (Required)

Drug Discovery Industry Experience

10+ years in pharmaceutical/biotech marketing, business development, or commercial strategy

Deep understanding of clinical trial phases, regulatory pathways (FDA, EMA, Swissmedic)

Experience with drug candidate positioning, pharma partnerships, or licensing deals

Track record of building relationships with major pharma decision-makers

Wet Lab / Clinical Credibility

Hands-on knowledge of laboratory operations, chemistry, biology, or clinical workflows

Familiarity with manufacturing, scale-up, and GMP processes

Understanding of preclinical to clinical transition requirements

Can speak credibly to drug developers, chemists, and regulatory teams

Commercial Acumen

Experience in go-to-market strategy for biotech platforms

Success with partnership negotiations, licensing, or acquisition discussions

Understanding of portfolio value assessment and NPV modeling

B2B marketing to pharma and venture audiences

Bonus (Nice-to-Have)

Entrepreneurial spirit - you've launched something from zero to market

DACH region pharmaceutical networks (Deutschland, Österreich, Switzerland)

Data storytelling - can translate complex science into investor/partner narratives

The Role

Day-to-Day Responsibilities

Narrative & Positioning

Craft the generalAI story for investors, pharma partners, and the biotech ecosystem

Position our 20,000-candidate portfolio as the breakthrough platform it is

Create messaging around clinical validation, competitive advantage, and market timing

Emphasize Swiss biotech excellence and regulatory advantage (Swissmedic approvals faster in EU)

Business Development

Identify and pitch partnership opportunities with major pharma (acquisitions, licensing, R&D collaborations)

Build relationships with pharma business development teams, licensing groups

Support investor outreach for Series A (CHF 100M, 10M shares @ CHF 10) with CHF 43-72T portfolio backing

Negotiate with Roche, Novartis, Servier, and European pharma majors

Portfolio Marketing

Develop case studies for top 100 candidates (clinical protocols, NPV justifications in CHF)

Create regulatory strategy communications for FDA/EMA/Swissmedic pathways

Support IND-enabling studies marketing and timeline communication

Build compelling deck narratives around drug mechanism, market size, clinical potential

Ecosystem Building

Establish relationships with KOLs (key opinion leaders) in target therapeutic areas

Engage with pharma networks, conferences (JP Morgan, BIO CEO, Jefferies Healthcare)

Build credibility within drug discovery and biotech investment communities

Represent generalAI at industry events across DACH region and beyond

Strategic Planning

Lead market entry strategy for lead candidates

Develop 2-3 year commercial roadmap

Define target partner profiles and outreach sequences

Track competitive landscape and market intelligence

Work Structure

Remote Foundation

Primary: 100% remote, work from anywhere globally

Tool stack: Discord

Autonomy: Set your own hours; results-driven culture

Base: Zug headquarters optional (available for meetings)

Hybrid Flexibility (12+ months)

Future: Transition to hybrid model with optional Zug headquarters access

Lab access: Wet lab visits for candidate validation, partnership meetings, clinical site tours

Partner meetings: In-person pharmaceutical executive meetings (2-3x quarterly, primarily DACH region)

Investor meetings: JP Morgan Healthcare, BIO CEO, and other key conferences

Real Lab Access

This isn't a computational role - you'll have:

Direct access to our wet lab for hands-on candidate evaluation

Ability to observe synthesis, testing, formulation work

Participation in clinical protocol discussions with CMOs and CROs

Site visits with pharma partners and potential acquirers

Compensation & Equity

Salary

CHF 200, ,000 annually (depending on experience and location)

Equity

1% equity stake (vesting over 4 years, 1-year cliff)

Early-stage opportunity with Series A dilution understood

Warrant packages for major partnership closes

Benefits

Comprehensive health insurance (CHF coverage + international options)

6 weeks PTO + flexible working

Equipment stipend for remote setup

Professional development budget (conferences, courses)

Lab access and research account for professional development

Lunch stipend when in Zug office

Success Metrics (Year 1)

Q1-Q2: Build narrative for CHF 43-72T portfolio; identify 5 tier-1 pharma partners; secure initial partnership LOI

Q2-Q3: Negotiate first licensing or collaboration deal; launch investor roadshow with Swiss regulatory angle

Q3-Q4: Close Series A round (CHF 100M); execute first pharma partnership in DACH region

Year 1: Position 10+ candidates for clinical advancement; establish generalAI as Europe's leading AI drug discovery platform

Why Join generalAI

Impact: Lead marketing for 20,000 drug candidates (CHF 43-72T portfolio) that could transform medicine across 76 therapeutic areas

Upside: Early equity in pre-Series A biotech platform representing ~14% of global wealth

Team: Work with PhDs, biologists, chemists, and AI researchers who've already cracked the hard problems

Clarity: You know what success looks like—partnerships, deals, clinical progress, funding closed

Swiss Advantage: Based in Zug (crypto valley + pharma hub); Swissmedic approvals = EU + CHF 100M Series A already targeted

Application Process

What We Need From You

Resume/CV - Highlight pharmaceutical/biotech marketing or business development roles

Cover Letter - Tell us why you understand drug discovery AND why this platform excites you (1-2 paragraphs)

Portfolio Example - One deal you've led, one market entry you've executed, or one partnership you've built (1 page)

References - 2-3 pharma executives or biotech leaders who know your work

Timeline

Rolling applications - Apply now for Q1 2026 start

First round: 30-minute call with our founding team (no prep needed—just talk about your drug discovery work)

Second round: Deep dive with me (CMO hiring lead) on pharma partnerships you've led

Third round: Meet the CEO and investment team; discuss equity and vision

The Pitch (TL;DR)

We've discovered 20,000 drugs using AI. We need someone who can sell that story to pharma, close partnerships, and guide our Series A. You understand drug development, can speak to wet lab teams, and know how to negotiate big deals.

This is CMO for a biotech platform on the verge of breaking out—not a computational role. Just business acumen, pharma credibility, and the ability to recognize a generational opportunity.

Based in Switzerland. CHF 43-72 TRILLION portfolio. CHF K salary + equity. Ready?

How to Apply

Email:

Subject: CMO - Drug Discovery Experience | [Your Name]

Questions? Reply here or DM me directly—we move fast.

LinkedIn: Tag @generalAI or @Michael (Founder)

What's Confidential

Candidate list details (we'll share top 100 in data room post-NDA)

Portfolio NPV calculations (proprietary algorithm)

Pharma partner discussions (in progress)

Series A investor list (strategic)

Everything else is open for discussion.

Context: Scale of Our Discovery

Our 20,000-candidate portfolio (CHF 43-72T) represents approximately 13.78% of total global wealth ($463T USD equivalent). Global M3 (money supply) is $28.2T USD.

We're not just building a pharma company—we're potentially reshaping the entire pharmaceutical landscape. This CMO role is your chance to lead that narrative from day one.

generalAI is an equal opportunity employer. We welcome candidates from all backgrounds. No computational experience required—drug discovery industry knowledge and pharma relationships are what matter.

Last Updated: December 3, 2025

Series A Fundraising Phase | Zug, Switzerland (Remote → Hybrid)